Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexis Laux

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Molecular Pain|December 22, 2010
Abnormal nociception and opiate sensitivity of STOP null mice exhibiting elevated levels of the endogenous alkaloid morphineAlexandre Charlet, Arnaud H Muller, Alexis Laux, et al.
Molecular Pharmacology|June 22, 2023
Discovery and In Vitro Characterization of BAY 2686013, an Allosteric Small Molecule Antagonist of the Human Pituitary Adenylate Cyclase-Activating Polypeptide ReceptorGernot Langer, John Scott, Christoffer Lind, et al.
British Journal of Pharmacology|July 28, 2018
Stable isotope-labelled morphine to study in vivo central and peripheral morphine glucuronidation and brain transport in tolerant miceIvan Weinsanto, Alexis Laux-Biehlmann, Jinane Mouheiche, et al.
Biofactors (Oxford, England)|July 18, 2013
Endogenous morphine-6-glucuronide (M6G) is present in the plasma of patients: validation of a specific anti-M6G antibody for clinical and basic researchAlexis Laux-Biehlmann, Hélène Chung, Jinane Mouheiche, et al.
Journal of Medicinal Chemistry|November 21, 2019
Discovery and Characterization of the Potent and Selective P2X4 Inhibitor <i>N</i>-[4-(3-Chlorophenoxy)-3-sulfamoylphenyl]-2-phenylacetamide (BAY-1797) and Structure-Guided Amelioration of Its CYP3A4 Induction ProfileStefan Werner, Stefanie Mesch, Roman C Hillig, et al.
Brain : a Journal of Neurology|July 12, 2011
Endogenous morphine-like compound immunoreactivity increases in parkinsonismGiselle Charron, Evelyne Doudnikoff, Alexis Laux, et al.
Brain Structure & Function|March 21, 2014
Defective response inhibition and collicular noradrenaline enrichment in mice with duplicated retinotopic map in the superior colliculusChantal Mathis, Elise Savier, Jean-Bastien Bott, et al.
Scientific Reports|October 7, 2021
Eliapixant is a selective P2X3 receptor antagonist for the treatment of disorders associated with hypersensitive nerve fibersAdam J Davenport, Ioana Neagoe, Nico Bräuer, et al.
Journal of Medicinal Chemistry|January 9, 2023
Discovery of <b>BAY-390</b>, a Selective CNS Penetrant Chemical Probe as Transient Receptor Potential Ankyrin 1 (TRPA1) AntagonistStefanie Mesch, Daryl Walter, Alexis Laux-Biehlmann, et al.
Plos One|January 26, 2010
Endogenous morphine levels are increased in sepsis: a partial implication of neutrophilsElise Glattard, Ingeborg D Welters, Thomas Lavaux, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Molecular Pain|December 22, 2010
Abnormal nociception and opiate sensitivity of STOP null mice exhibiting elevated levels of the endogenous alkaloid morphineAlexandre Charlet, Arnaud H Muller, Alexis Laux, et al.
Molecular Pharmacology|June 22, 2023
Discovery and In Vitro Characterization of BAY 2686013, an Allosteric Small Molecule Antagonist of the Human Pituitary Adenylate Cyclase-Activating Polypeptide ReceptorGernot Langer, John Scott, Christoffer Lind, et al.
British Journal of Pharmacology|July 28, 2018
Stable isotope-labelled morphine to study in vivo central and peripheral morphine glucuronidation and brain transport in tolerant miceIvan Weinsanto, Alexis Laux-Biehlmann, Jinane Mouheiche, et al.
Biofactors (Oxford, England)|July 18, 2013
Endogenous morphine-6-glucuronide (M6G) is present in the plasma of patients: validation of a specific anti-M6G antibody for clinical and basic researchAlexis Laux-Biehlmann, Hélène Chung, Jinane Mouheiche, et al.
Journal of Medicinal Chemistry|November 21, 2019
Discovery and Characterization of the Potent and Selective P2X4 Inhibitor <i>N</i>-[4-(3-Chlorophenoxy)-3-sulfamoylphenyl]-2-phenylacetamide (BAY-1797) and Structure-Guided Amelioration of Its CYP3A4 Induction ProfileStefan Werner, Stefanie Mesch, Roman C Hillig, et al.
Brain : a Journal of Neurology|July 12, 2011
Endogenous morphine-like compound immunoreactivity increases in parkinsonismGiselle Charron, Evelyne Doudnikoff, Alexis Laux, et al.
Brain Structure & Function|March 21, 2014
Defective response inhibition and collicular noradrenaline enrichment in mice with duplicated retinotopic map in the superior colliculusChantal Mathis, Elise Savier, Jean-Bastien Bott, et al.
Scientific Reports|October 7, 2021
Eliapixant is a selective P2X3 receptor antagonist for the treatment of disorders associated with hypersensitive nerve fibersAdam J Davenport, Ioana Neagoe, Nico Bräuer, et al.
Journal of Medicinal Chemistry|January 9, 2023
Discovery of <b>BAY-390</b>, a Selective CNS Penetrant Chemical Probe as Transient Receptor Potential Ankyrin 1 (TRPA1) AntagonistStefanie Mesch, Daryl Walter, Alexis Laux-Biehlmann, et al.
Plos One|January 26, 2010
Endogenous morphine levels are increased in sepsis: a partial implication of neutrophilsElise Glattard, Ingeborg D Welters, Thomas Lavaux, et al.
Pageof 3